Investor · Mountain View, CA

Felix J. Baker

Open Felix in the network graph →

Filings

8

SEC Form D

Connections

47

co-filers

Capital

$578.0M

across filings

Active

Mar 2011

to Jun 2024

Most-connected co-filers (47)

Mark Goldberg · SAN FRANCISCO, CA6 shared Stephen R. Biggar · Vancouver, British Columbia, Canada4 shared Robyn Samuels · Waltham, MA4 shared Sanj K. Patel · Waltham, MA4 shared Lyle K. Hohnke · Andover, MA4 shared Timothy Redmond · Aptos, CA3 shared Mark R. Retzloff · Boulder, CO3 shared Thomas Malley · SAN DIEGO, CA3 shared James Rogers · San Mateo, CA3 shared Lou Salfi · San Mateo, CA3 shared Christofer Schneider · San Mateo, CA3 shared Jaap Langenberg · Aptos, CA3 shared Joseph Cohen · San Diego, CA2 shared Kevin D. Hoyle · San Diego, CA2 shared Mark Delfino · San Diego, CA2 shared Srini Akkaraju · Agoura Hills, CA2 shared John Battendieri · Aptos, CA2 shared James L. Tullis · Palm Beach Gardens, FL2 shared Christina Topsoe · Brooklyn, NY1 shared Chris H. Takimoto · Mountain View, CA1 shared M. Kathleen J. Behrens · Mountain View, CA1 shared Bruce A. Keyt · Mountain View, CA1 shared William J. Strohl · Mountain View, CA1 shared Michael J. Loberg · Mountain View, CA1 shared

Recent filings (8)

BICYCLE THERAPEUTICS PLCJun 2024 · 29 co-filers$555.5M BICYCLE THERAPEUTICS PLCJun 2024 · 29 co-filers$555.5M IGM Biosciences, Inc.Jul 2023 · 27 co-filers$22.5M IGM Biosciences, Inc.Jul 2023 · 27 co-filers$22.5M SYNAGEVA BIOPHARMA CORP.Mar 2011 · 11 co-filers$25.0M SYNAGEVA BIOPHARMA CORP.Mar 2011 · 11 co-filers$25.0M ENHANCED INCOME FUND I LLCMar 2011 · 5 co-filers$100.0M SYNAGEVA BIOPHARMA CORP.Aug 2010 · 13 co-filers$45.0M SYNAGEVA BIOPHARMA CORP.May 2009 · 13 co-filers$45.0M SYNAGEVA BIOPHARMA CORPApr 2009 · 13 co-filers$45.0M ENHANCED INCOME FUND I LLCApr 2009 · 5 co-filers$100.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Felix in the interactive graph →